We are live on ! Find out more
TG

TRV GP Portfolio holdings

AUM $18.9M
1-Year Est. Return 541.67%
This Fund
S&P 500
This Quarter Est. Return
-33.97%
1 Year Est. Return
+541.67%
3 Year Est. Return
+3,178.23%
5 Year Est. Return
10 Year Est. Return
AUM
$50.9M
AUM Growth
-$97M
Cap. Flow
-$52.1M
Cap. Flow %
-102.39%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$48.2M 94.67%
1,534,083
-1,500,000
-49% -$52.1M
CARM
2
DELISTED
Carisma Therapeutics
CARM
$2.72M 5.33%
242,080

Similar funds

TRV GP's Q1 2020 Portfolio in Review

As of Q1 2020, TRV GP held 2 positions worth $50.9M, down 66% from $148M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP withdrew a net $52.1M in Q1 2020, reducing 1 holding. Its largest reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $52.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP's biggest Q1 2020 reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $52.1M.
  • TRV GP's ten largest holdings make up 100% of its $50.9M portfolio in Q1 2020.
  • TRV GP opened 0 new positions and closed 0 in Q1 2020.
  • TRV GP's portfolio value fell 66% quarter-over-quarter to $50.9M.

Based on TRV GP's 13F filing for Q1 2020, filed 11 May 2020.